Anandamide and THC Did Not Produce Identical Adaptation in FAAH-Deficient Mice
Repeated anandamide and THC exposure produced different receptor adaptations in genetically modified mice. The comparison does not show that increasing any endogenous cannabinoid is automatically free of tolerance or dependence.
Why the knockout model was used
Anandamide is normally broken down rapidly by fatty acid amide hydrolase, or FAAH. Removing that enzyme allowed researchers to examine repeated anandamide exposure alongside THC. Behavioral testing included pain-related responses, immobility and body temperature; laboratory assays examined receptor binding and signaling.
Adaptation and the challenge drug mattered
Repeated THC produced greater receptor downregulation and desensitization than repeated anandamide in this model. However, the apparent magnitude of behavioral tolerance also depended on which drug was used during the later test. Tolerance was not simply a direct readout of the earlier treatment label.
Dependence was probed with an antagonist
Rimonabant precipitated stronger withdrawal responses after repeated THC than after repeated anandamide. This is an experimentally triggered withdrawal model, not spontaneous cessation in human cannabis users. A smaller response is also a relative result rather than proof of zero dependence potential.
The research boundary
A lifelong genetic enzyme deletion differs from administering an enzyme inhibitor to an adult patient. Mouse doses, altered metabolism and selected tasks further limit translation. Receptor measurements came from nervous-system tissue, not a validated human blood marker of tolerance. The paper supports distinguishing ligands and mechanisms when developing treatments; it does not establish the safety of a supplement or provide an individual cannabis-impairment rule.
Related analysis: evaluating cannabis tolerance claims.
Primary research
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2010). DOI: 10.1038/npp.2010.44.
